Automating MEDITECH Keytruda Prior Authorization Workflows

Klivira streamlines MEDITECH Keytruda prior authorization, enabling community hospitals and health systems to accelerate approvals for this critical oncology medication.

The operational burden of Keytruda prior authorization within MEDITECH environments presents a significant challenge for revenue cycle directors and prior authorization coordinators. Managing the high volume of Keytruda PAs, which often span both medical and pharmacy benefits, demands a robust and integrated ePA solution. Klivira offers a specialized approach to automate these complex workflows, reducing manual effort and improving turnaround times.

Navigating Keytruda Prior Authorization within MEDITECH Environments

Keytruda (pembrolizumab) is a high-volume prior authorization target across commercial, Medicare Advantage, and Medicaid managed care plans. Its therapeutic applications often require extensive clinical documentation and adherence to payer-specific medical policies. Integrating an efficient ePA solution with MEDITECH is crucial for managing the associated administrative workload and ensuring timely patient access to this vital therapy, particularly in community hospital settings where MEDITECH has a strong footprint.

MEDITECH Integration Pathways for ePA Automation

Klivira leverages MEDITECH's diverse integration surfaces to embed prior authorization automation directly into clinical workflows. For MEDITECH Expanse customers, we utilize FHIR R4 APIs and SMART App Launch capabilities for seamless data exchange and application access from the clinical desktop. For organizations operating MEDITECH 6.x, C/S, or Magic, Klivira also supports traditional HL7 v2 interfaces, which remain operationally essential for ADT, ORM/ORU, and MDM event capture in many deployments.

Streamlining Keytruda PA Documentation from MEDITECH

Effective Keytruda prior authorization relies on comprehensive clinical documentation. Klivira's platform is engineered to extract relevant data points from MEDITECH, including patient demographics from the Patient Summary/Storyboard, clinical notes from Documentation modules, and problem lists. This automated data gathering from the EMR minimizes manual chart abstraction, ensuring that PA requests are submitted with the necessary supporting evidence, reducing the likelihood of denials due to incomplete information.

Addressing Keytruda's Medical vs. Pharmacy Benefit Complexity

Keytruda often falls under the medical benefit for administration in a clinical setting, while other oncology drugs may be covered under the pharmacy benefit. Klivira's platform is designed to identify and correctly route prior authorization requests based on this critical distinction, whether via X12 278 for medical benefit or NCPDP SCRIPT for pharmacy benefit, where applicable. This ensures the appropriate PA process is initiated, aligning with payer requirements and avoiding processing delays.

Optimizing the Keytruda Order-to-Approval Workflow

From the point of order entry in MEDITECH's Orders activity, Klivira initiates the ePA process. Our integration helps manage specialty pharmacy routing by providing real-time PA status updates. In MEDITECH Expanse, these updates can surface in Surveillance/Worklists or Communication/Messaging modules, enabling prior authorization coordinators to track progress and intervene proactively. This end-to-end automation reduces administrative burden and accelerates time-to-therapy for Keytruda.

Frequently asked questions

How does Klivira handle different MEDITECH product lines for Keytruda PA?

Klivira accommodates the variability across MEDITECH product lines. For modern Expanse deployments, we utilize FHIR R4 APIs and SMART App Launch. For legacy systems like 6.x, C/S, or Magic, we integrate via established HL7 v2 interfaces to ensure comprehensive coverage and operational continuity for Keytruda prior authorizations.

What documentation does Klivira pull from MEDITECH for Keytruda prior authorizations?

Klivira's platform is configured to extract key clinical documentation from MEDITECH that supports Keytruda prior authorization requests. This includes patient demographics, clinical notes, problem lists, and order details, all essential for meeting payer medical policy requirements and justifying medical necessity.

Does Klivira support write-back of PA status into MEDITECH?

Klivira can deposit prior authorization artifacts and status updates into MEDITECH. Write-back capabilities, such as for DocumentReference (PA packet upload), Communication (status messages), or Task (workflow items) on MEDITECH Expanse, are verified per customer to ensure seamless integration with their specific EMR configuration.

How does Klivira differentiate between medical and pharmacy benefit for Keytruda PAs?

Our platform is designed to identify whether Keytruda prior authorization falls under the medical or pharmacy benefit. This distinction dictates the appropriate electronic submission standard (e.g., X12 278 for medical benefit, NCPDP SCRIPT for pharmacy benefit) and ensures the request is routed correctly, preventing delays due to incorrect submission pathways.

Is Klivira compatible with MEDITECH's specialty pharmacy routing?

Yes, Klivira supports the integration points necessary to facilitate specialty pharmacy routing for Keytruda. By providing timely prior authorization approvals and status updates, our platform helps ensure that the medication can be dispensed and administered without unnecessary delays, aligning with the overall treatment plan.